WNT4 and osteoporosis: A recent study [74] reported that curculigoside, the active anti-osteoporosis compound extracted from Curculigo orchioides Gaertn, could targetedly activate ERK1 and then regulate the WNT4 expression in MC3T3-E1 cells (data under submission).